U
NUVA

UBS’s NuVasive, Inc. NUVA Stock Holding History

UBS’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$678K Hold
19,430
– – ﹤0.01% 3983
2014
Q2 		$691K Sell
19,430
-3,709
-16% -$127K ﹤0.01% 3909
2014
Q1 		$888K Buy
23,139
+2,478
+12% +$91K ﹤0.01% 3605
2013
Q4 		$668K Buy
20,661
+3,964
+24% +$119K ﹤0.01% 4009
2013
Q3 		$409K Buy
16,697
+5,496
+49% +$135K ﹤0.01% 4370
2013
Q2 		$277K Buy
+11,201
New +$245K ﹤0.01% 4740

Other funds holding NUVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

UBS's NUVA Position: Q3 2014 in Review

UBS held its NuVasive, Inc. (NUVA) position steady in Q3 2014 at 19,430 shares worth $678K. The position accounts for ﹤0.01% of the portfolio, ranked #3983.

UBS first reported a position in NUVA in Q2 2013 and has held it in 6 quarters since. The position peaked at $888K in Q1 2014. 182 funds tracked by Wall St. Rank hold NUVA as of Q3 2014.

  • UBS held 19,430 shares of NuVasive, Inc. worth $678K as of Q3 2014.
  • UBS left its NuVasive, Inc. share count unchanged in Q3 2014.
  • NuVasive, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3983 holding.
  • UBS first reported a position in NuVasive, Inc. in Q2 2013 and has held it in 6 quarters since.
  • UBS's NuVasive, Inc. position peaked at $888K in Q1 2014.
  • 182 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.